VC firms
Sambrinvest est un acteur privé de capital à risque actif dans la région de Charleroi Métropole. Il a pour objet l'accompagnement et le développement des PME et des startups. Par son expertise, il conseille les entrepreneurs, à chaque stade de développement de leurs projets, tout en respectant leur autonomie de gestion.
Overview
Location
Belgium, Hainaut, Gosselies
Employees
11-50
Phone
+32 71 25 94 96
Founded date
1985
Investment Type
Venture Capital
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jun 8, 2023 | Santero Medical | santero.be | $8.57M |
Mentions in press and media 14
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 11, 2026 | Enodia Therapeutics Secures €20.7M Seed Funding to Pioneer Protein Degradation with AI | Enodia Therapeutics, a pioneering biotech firm, secured a significant €20.7 million ($25 million) seed funding round. This vital capital propels its innovative small-molecule platform, a breakthrough approach targeting protein degradation a... |
| Jan 11, 2026 | Enodia Therapeutics Raises €20.7M to Target "Undruggable" Proteins with SEC61 Platform | Enodia Therapeutics, a Paris-based biotech, has secured €20.7 million ($25 million) in seed funding. Argobio Studio launched the company. Enodia develops small molecules. Its platform targets protein degradation at the point of synthesis. I... |
| Jan 10, 2026 | Enodia Therapeutics: €20.7 Million Seed Funding Closed To Advance SEC61-Based Small-Molecule Protein Degradation Platform | Enodia Therapeutics has raised €20.7 million (about $25 million) in a seed financing to advance a discovery platform that uses proteomics and machine learning to develop small molecules that degrade disease-driving proteins at the point of ... |
| Jan 8, 2026 | Enodia Therapeutics Raises €20.7M in Seed Funding | Enodia Therapeutics, a Paris, France-based biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, raised €20.7m (US$25m) in Seed financing. The round was co-led by Elaia, ... |
| Oct 1, 2025 | Sunrise Group: $29 Million Raised For Expanding Dreem Health | Sunrise Group, known as a leader in sleep health technology, has announced a funding round of $29 million dedicated to expanding Dreem Health, its innovative digital sleep clinic, to ensure its services reach all 50 states in the U.S. This ... |
| Sep 25, 2025 | Sunrise Group Raises $29M to Expand Dreem Health and Build the Largest U.S. Sleep Clinic | What You Should Know: –Sunrise Group, a leader in sleep health technology, today announced a $29 million funding round to expand Dreem Health, its digital sleep clinic, across all 50 states. – The round was led by Eurazeo, with participatio... |
| May 16, 2024 | Aerospacelab breaks ground on Europe's largest satellite manufacturing facility | Megafactory capable of building 500 satellites a year represents a significant step forward in European space capabilities and readiness MONT-SAINT-GUIBERT, Belgium, May 16, 2024 /PRNewswire/ -- Aerospacelab, a fast-growing satellite manufa... |
| Oct 20, 2023 | New investment fund welovefounders injects €35M into the B2B SaaS ecosystem | This week sees the launch of a €35 million investment fund with the charming moniker welovefounders. The fund out of Brussels primarily focuses on B2B SaaS startups but is sector-agnostic. The minimum investment amount is €500,000, with the... |
| Sep 1, 2023 | Belgium-based Cikisi raises €2.7M to expand its market intelligence tool | Read this article in: Belgium-based Cikisi announced it had raised €2.7M in a pre-Series A round of funding. The company says the funding will accelerate Cikisi’s growth and extend its market reach within the next two years. Angelwise, a Be... |
Show more
Reviews 0
FAQ about SambrInvest
When was SambrInvest founded?
SambrInvest was founded in 1985.
How many startups has SambrInvest invested in?
SambrInvest has 2 portfolio companies on Parsers VC, among them Santero Medical.
What has the press written about SambrInvest?
Parsers VC has collected 14 articles mentioning SambrInvest, among them “Enodia Therapeutics Secures €20.7M Seed Funding to Pioneer Protein Degradation with AI” (Jan 11, 2026) and “Enodia Therapeutics Raises €20.7M to Target "Undruggable" Proteins with SEC61 Platform” (Jan 11, 2026).
Is SambrInvest still active?
Yes, SambrInvest is active; its latest activity on Parsers VC dates from Jul 21, 2026.